Wednesday, Jan 28 / 2026
Virtual Meeting
  • Wednesday, January 28, 2026
  • 10:00 AM - 11:00 AM PST
  • Virtual Only
  • → Join Online
  • Access will be granted upon approval
Download for Outlook/Apple Calendar Add to Google Calendar

DD Call with ReEngage

ReEngage Therapeutics, Inc.
ReEngage Therapeutics, Inc., is a clinical stage oncology company focused on developing novel treatments for longevity-related diseases, including neurodegeneration and cancer. The company is developing a de-risked molecule, MTB-9655, to treat 3rd line metastatic colorectal cancer.

Presenting companies:

ReEngage Therapeutics, Inc.
ReEngage Therapeutics, Inc.

ReEngage Therapeutics, Inc., is a clinical stage oncology company focused on developing novel treatments for longevity-related diseases, including neurodegeneration and cancer. The company is developing a de-risked molecule, MTB-9655, to treat 3rd line metastatic colorectal cancer.